, Tracking Stock Market Picks
Enter Symbol:
Acorda Therapeutics, Inc. (ACOR) [hlAlert]

down 19.97 %

Acorda Therapeutics, Inc. (ACOR) rated Sell by Morgan Joseph

Posted on: Thursday,  Jan 31, 2008  12:25 PM ET by Morgan Joseph

Morgan Joseph rated Sell Acorda Therapeutics, Inc. (NASDAQ: ACOR) on 01/31/2008, when the stock price was $25.36. Since
then, Acorda Therapeutics, Inc. has gained 24.96% as of 01/26/2016's recent price of $31.69.
If you would have followed this Morgan Joseph's recommendation on ACOR, you would have lost 19.97% of your investment in 2917 days.

Acorda Therapeutics is commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Acorda currently markets Zanaflex Capsules for the management of spasticity. The Company's lead product candidate, Fampridine-SR, for the improvement of walking ability in persons with multiple sclerosis. It develops therapies that restore neurological function to people with spinal cord injury, multiple sclerosis and related conditions of the nervous system.

Morgan Joseph is committed to providing timely, objective and actionable investment advice on the companies and securities we follow. Our team of equity analysts covers a growing universe of stock issues across a broad range of industry sectors. As a middle market-focused firm, our approach is not to publish research on as many companies as possible within a number of industry sectors. Rather, our research analysts distinguish themselves by zeroing in on quality companies with growth prospects or which present special situations. These companies often lack a research following. This enables our analysts to provide insight to investors in companies that are not well understood nor fairly valued.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/31/2008 12:25 PM Sell
as of 12/24/2008
1 Week down  -15.07 %
1 Month up  16.03 %
3 Months up  12.15 %
1 YTD down  -5.70 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy